Is Integra LifeSciences (IART) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Hold IART Stock in Your Portfolio Now
Integra's growth within its Tissue Technologies business segment bolsters investors' confidence in the stock.
Reasons to Retain IART Stock in Your Portfolio for Now
Integra's strong growth in the CSS business segment bolsters investors' confidence in the stock. Meanwhile, the weak liquidity position adds to the worry.
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
According to a health economic evaluation, Integra's DuraSeal Dural Sealant is revealed to reduce healthcare costs.
Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure
IART is optimistic about the fact that the shipping holds have largely been resolved within the third quarter.
Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q3 2024 Earnings Call Transcript November 4, 2024 8:30 AM ET Company Participants Chris Ward - IR Stuart Essig - Executive Chairman Jan De Witte - President and CEO Lea Knight - CFO Conference Call Participants Steven Lichtman - Oppenheimer Vik Chopra - Wells Fargo Ryan Zimmerman - BTIG Kristen Stewart - C.L. King Robbie Marcus - JPMorgan Matt Taylor - Jefferies Richard Newitter - Truist Securities Craig Bijou - Bank of America Securities Joanne Wuensch - Citi Chris Ward Good morning and thank you for joining the Integra LifeSciences Third Quarter 2024 Earnings Conference Call.
Integra (IART) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
Integra LifeSciences (IART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.76 per share a year ago.
Here's Why You Should Hold IART Stock in Your Portfolio Now
Integra's strong growth in the Tissue Technologies and CSS business segment bolsters investors' confidence in the stock.
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
Integra LifeSciences IART reported upbeat second-quarter earnings and lowered its FY24 guidance below estimates on Monday.
Why Integra Lifesciences Stock Is Sinking Today
Integra Lifesciences topped analysts' Q2 revenue and earnings estimates. However, the company reduced its full-year guidance.
